Global Wound Care Medical Group: $10.7M DIP and Medicare-Driven Shutdown

Global Wound Care Medical Group, a Professional Corporation, filed for chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division, on October 21, 2024, as Case No. 24-34908 before Judge Christopher M. Lopez. The filing followed a September 11, 2024 Medicare payment suspension that cut off the revenue of a practice that drew roughly 90% of its income from Medicare, turning a liquidity emergency into a court-supervised restructuring almost overnight.

What began as an attempt to preserve wound-care operations for elderly patients moved through a negotiated truce with the federal government, a $10.7 million debtor-in-possession facility, and ultimately a full operational shutdown. By spring 2026 the estate had ceased treating patients, terminated nearly its entire workforce, and was holding cash while counsel pursued a global settlement with the Department of Justice that the debtor described as the precondition for converting the case to chapter 7. The case is a study in how a single regulatory action against a government-dependent healthcare provider can drive a going concern into wind-down.

Debtor	Global Wound Care Medical Group, a Professional Corporation
Court	U.S. Bankruptcy Court, Southern District of Texas (Houston Division)
Case Number	24-34908
Petition Date	October 21, 2024
Judge	Hon. Christopher M. Lopez
DIP Facility	$10.7 million from East West Bank (Wound Pros Management Group, Inc. as guarantor); interim order entered October 29, 2025

Open the public case profile for docket context, hearings, advisors, and plan updates.

Medicare Suspension and the Path to chapter 11

Global Wound Care described itself in its first day declaration as a wound-care medical practice serving elderly patients in homes, hospices, and skilled nursing facilities, using a proprietary AI-enabled assessment tool called RITA. The declaration of Ralph Cetrulo reported that the debtor was licensed in more than 20 states and had treated 9,620 patients across 161,967 encounters in 2024, with 248 full-time and 36 part-time employees. Equity was held by Owen B. Ellington, M.D., and non-clinical management functions were performed by Wound Pros Management Group, Inc. under a management services agreement.

The trigger for the filing was regulatory. The first day declaration tied the chapter 11 to a September 11, 2024 Medicare payment suspension imposed by Qlarant Integrity Solutions based on alleged credible allegations of fraud tied to five claims totaling $11,150.65. For a business that the debtor said drew approximately 91% of its 2023 revenue from government healthcare programs — and roughly 90.28% of trailing revenue from Medicare specifically — the suspension cut off the primary revenue stream and, in the debtor's telling, threatened the continuity of patient care. The debtor filed in Texas rather than its California home base, joining the Southern District of Texas's complex-case docket.

The capital structure was dominated by an intercompany obligation. The debtor reported approximately $187.3 million in assets and $157.1 million in liabilities as of October 20, 2024, including more than $155.6 million allegedly owed to Wound Pros under the management-services arrangement. That related-party charge — the affiliate that also performed the debtor's back-office functions — became a central feature of the case and a focus of later restrictions on payments to insiders. The Wound Pros enterprise, founded by Dr. Bill Releford, had its own regulatory history: CMS had previously revoked the Medicare enrollments of Wound Pros Arizona and Wound Pros Nevada as DMEPOS suppliers in 2023.

The filing also drew government scrutiny early. Within weeks, the Department of Justice told the court that the company was under federal investigation, foreshadowing the settlement negotiations that would gate the case for the next eighteen months. The distress fit a broader pattern of intensifying Medicare audits of skin-substitute claims, where Part B expenditures had exceeded $1.6 billion in a single quarter of 2023, and tracked a wider surge in healthcare sector chapter 11 filings through 2024.

HHS Stipulation and Government Setoff Rights

The first major negotiated event was a truce over the suspended payments. On December 19, 2024, the court entered a stipulation and agreed order with HHS and DOJ governing the Medicare payment suspension. Under that deal, CMS agreed to release 75% of amounts payable on claims submitted on or after the effective date while continuing to suspend the remaining 25% of post-effective-date claims. Roughly $208 million of previously suspended amounts remained frozen, leaving the debtor able to operate on a partial cash flow without recovering the bulk of its prepetition receivable.

The price of that partial cash flow was a broad grant of government rights. The same stipulation gave the United States setoff rights against previously suspended payments, continuing suspended payments, the Medicare receivables account, and other amounts owed to the debtor, plus a section 507(b) superpriority administrative claim for released payments not satisfied through offset, subject to a carve-out. The debtor also agreed to restrictions on payments to owners, related individuals, and related entities — including Wound Pros — absent government consent, other than budgeted exceptions.

The arrangement was deliberately short-lived. The stipulation carried automatic expiration on December 31, 2024 unless extended, along with earlier termination triggers tied to appointment of a trustee, conversion, dismissal, exclusion from Medicare, uncured debtor breaches, or a DOJ-declared settlement impasse. Those mechanics kept the government in a controlling position over the estate's liquidity throughout the case.

Liquidity Crisis and the East West Bank DIP

The détente did not hold operationally. By October 2025, the debtor told the court that an extreme slowdown in Medicare reimbursements had pushed it toward an imminent shutdown, a problem compounded by a federal government shutdown as it awaited some $27.2 million in reimbursements. In a declaration responding to issues raised at a status conference, CRO Louis E. Robichaux IV said combined cash had fallen to about $14 million against near-term obligations that included roughly $3.9 million of payroll, $7.7 million owed to biologic vendors, and $1.8 million owed to other vendors. He warned that cash could fall to about $6 million by the week ending October 31, 2025.

To bridge the gap, the debtor on October 28, 2025 sought authority to obtain a $10.7 million DIP facility from East West Bank, with Wound Pros Management Group as guarantor. The motion described a 12% interest rate, a 4% commitment fee payable on entry of the interim order, a 4% exit fee, a 1% PIK extension fee for each 30-day extension, and maturity at the earliest of 120 days after the interim order or other customary chapter 11 endpoints, including a sale, plan consummation, dismissal, conversion, trustee appointment, or acceleration after default.

Because the government already held layered rights under the Medicare stipulation, the DIP motion described a negotiated lien and superpriority structure intended to preserve those interests. The facility provided for pari passu treatment with any superpriority claims granted to the United States and junior treatment on Medicare receivables if the government did not consent to priming. The debtor framed the financing as necessary to avoid a shutdown that would disrupt patient care and destroy going-concern value.

The court moved quickly. It entered the interim DIP order on October 29, 2025, approving the full $10.7 million commitment from East West Bank and authorizing the debtor to draw the entire amount in a single draw on the interim closing date. The order granted the DIP lender liens and superpriority administrative claims, modified the automatic stay, scheduled a final hearing, and found the facility's fees, expenses, and charges fair and reasonable. The debtor filed a proposed final order on November 17, 2025 authorizing the same $10.7 million facility on a final basis, with a redline against the interim order attached and no increase to the commitment amount.

Operational Shutdown and Patient-Record Disposal

Within weeks of securing the DIP, the case pivoted from rescue to wind-down. At a December 1, 2025 status conference, debtor's counsel reported that Global Wound Care and Wound Pros were suspending operations following a CMS final rule, and that 429 of 1,830 active patients — about 43% — had already been referred to new providers. Counsel said the debtor aimed to transfer all patients by December 12, 2025, and that employees and medical directors had been told December 12 would be their last day of service. The affiliated manager publicly announced the cessation of all business and clinical operations across every service state effective the same date.

By the January 20, 2026 status conference, counsel told the court that the government was not paying the debtor, that negotiations with DOJ were continuing, and that the debtor expected to convert the case to chapter 7 after reaching a settlement. Counsel also previewed a section 351 motion for patient-record handling along with housekeeping motions involving leases and contracts.

The records motion landed on February 13, 2026. The section 351 motion stated that the debtor had decided to wind down after a slowdown in Medicare claims processing and a new CMS rule that reduced Medicare reimbursements by roughly 90%, that operations had ceased, that most staff had been terminated by the end of December 2025, and that all patients had been transferred to new wound-care providers. The motion proposed using Iron Mountain as records custodian for a $5,950 fee plus tax, with records exported from the debtor's RITA system, encrypted, and uploaded to a secure cloud environment. It proposed a 365-day waiting period after publication notice, direct mailed notices within 180 days to recent patients, insurers, and state attorneys general in the states where the debtor operated, and destruction after the waiting period if HHS did not request possession.

The court entered the records-disposal order on April 6, 2026, approving the disposal procedures and extending the authority to any successor, including a chapter 7 trustee. The order required published notice in the Los Angeles Times, USA Today, and the Houston Chronicle; direct notice to patients treated within the prior 12 months, insurers, and the attorneys general of states where the debtor operated; and notice to HHS and DOJ offering to deposit unclaimed records, with destruction permitted only if those agencies declined possession after the waiting period. The debtor remained obligated to preserve and produce records responsive to federal investigations, litigation discovery, or Medicare demands before any destruction, and an affidavit of publication for the notice was filed on May 8, 2026.

Wells Fargo Transition and Wind-Down Financials

A parallel dispute over the debtor's bank accounts resolved into a transition schedule in early 2026. The second amended Wells Fargo stipulation, entered February 20, 2026, set final milestones for moving into replacement accounts: the debtor had to submit CMS-588 forms for all states by February 28, 2026, complete the transition of government receivables by March 31, 2026, and close the Wells Fargo accounts by the earlier of March 31, 2026 or five business days after certifying that all receivables and disbursements had been transitioned. The stipulation sharply limited residual activity in the Wells Fargo accounts after those deadlines, generally permitting only automatic transfer activity and payroll-related exceptions while the move was finalized.

The estate's financial profile by then reflected a company that had stopped operating but retained a cash cushion. The monthly operating report for the period ending March 31, 2026 reported cash on hand of approximately $5.55 million at month end, total receipts of about $370,477, and total disbursements of about $41,120 for the month. No professional fees were paid during the month, leaving cumulative professional payments at roughly $5.15 million. The report listed gross income of $0 and a single remaining full-time employee, down from 248 at the order for relief, confirming that operations had effectively ceased.

Government Settlement and the chapter 7 Path

The chapter 7 conversion that counsel flagged in January 2026 remained tied to an unresolved government settlement through the spring. The debtor and the government extended the United States' proof-of-claim deadline through a March 2026 stipulation, moving the prior bar date of March 27, 2026 to August 1, 2026. The stipulation covered the Civil Division of the Department of Justice, HHS, and CMS, and stated that the parties were working consensually to resolve issues between them — a signal that the global settlement counsel had described as the gating event for conversion was not yet in hand.

Rather than convert or dismiss, the court kept the case in wind-down administration. At the April 6, 2026 status conference the parties provided a status report and the court continued the matter to May 11, 2026, with fee activity and government negotiations carrying on. Because the case has neither converted to chapter 7 nor confirmed a plan, there is no creditor class treatment or recovery data on the docket; the estate's posture remains a holding pattern pending the DOJ settlement.

Dentons, Ankura, and the Patient Care Ombudsman

Dentons US LLP served as chapter 11 counsel to the debtor. In its second interim fee application covering January 1 through March 31, 2025, Dentons sought $496,686.80 in fees and $2,887.23 in expenses, describing work on DOJ settlement and stipulation issues, reporting obligations under the Medicare arrangement, restructuring planning, Wells Fargo and cash-management matters, tax issues, and coordination with Ankura. Fee activity continued well into the wind-down, with Dentons filing its seventeenth monthly fee statement on May 12, 2026.

Ankura Consulting Group, LLC served as financial advisor, and the court approved the retention of Ankura and Isaac Lee as chief restructuring officer in January 2025. Ankura's fifth interim fee application, filed March 11, 2026, sought $220,276.50 in fees for the October 1 through December 31, 2025 period and stated that prior applications had been awarded a cumulative $2,096,384.50. A December 30, 2025 order on Ankura's fourth interim application followed the standard interim-compensation framework permitting payment of 80% of requested fees and 100% of requested expenses absent objection. Togut, Segal & Segal served as conflicts counsel and filed its ninth monthly fee statement on April 16, 2026.

Because the debtor was a healthcare business, the U.S. Trustee appointed a patient care ombudsman, Suzanne Richards, on November 4, 2024. Her interim compensation was later allowed in the amount of $11,511.50 in fees plus $159.60 of expenses, totaling $11,671.11.

Key Timeline

Date	Event
October 21, 2024	chapter 11 petition filed in the Southern District of Texas
October 24, 2024	First-day hearing held; complex-case treatment entered
November 4, 2024	Patient care ombudsman appointed
December 19, 2024	Medicare-payment stipulation entered with HHS and DOJ
January 14, 2025	Ankura and CRO Isaac Lee retention approved
October 28, 2025	DIP motion filed seeking $10.7 million from East West Bank
October 29, 2025	Interim DIP order entered approving the full facility
November 17, 2025	Proposed final DIP order filed
December 1, 2025	Status conference reports patient transfers and planned December 12 shutdown
January 20, 2026	Counsel says chapter 7 conversion is likely after a government settlement
February 13, 2026	Section 351 patient-records motion filed
February 20, 2026	Second amended Wells Fargo stipulation entered
March 6, 2026	U.S. proof-of-claim deadline extended to August 1, 2026
April 6, 2026	Patient-records disposal order entered; status conference continued to May 11, 2026
April 21, 2026	March 2026 monthly operating report filed showing about $5.55 million cash

Frequently Asked Questions

Why did Global Wound Care Medical Group file for chapter 11?

The debtor attributed the filing to a September 11, 2024 Medicare payment suspension imposed by Qlarant Integrity Solutions, which cut off the revenue of a practice that drew roughly 90% of its income from Medicare. The first day declaration described the suspension as an existential threat to a government-dependent wound-care business.

Who is the claims agent for Global Wound Care Medical Group?

Verita Global serves as the claims and noticing agent. The firm maintains the official claims register and case information portal for case 24-34908.

What happened to the company's operations?

Operations ceased in December 2025 after a CMS final rule that the debtor said reduced Medicare reimbursements by roughly 90%. All active patients were transferred to new wound-care providers, most staff were terminated by the end of December 2025, and by March 2026 the estate reported a single remaining full-time employee.

Has the case converted to chapter 7?

Not as of the latest docket activity. Counsel told the court the debtor expected to convert to chapter 7 after reaching a global settlement with the Department of Justice, and the parties extended the United States' proof-of-claim deadline to August 1, 2026 while those negotiations continued.

For more bankruptcy case coverage, visit the ElevenFlo bankruptcy blog.